Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Specificity-Verified Monoclonal Antibodies

publication date: Feb 6, 2015
 | 
author/source: AMSBIO

AMSBIO has announced the availability of ultraspecific and extensively validated monoclonal antibodies under the UltraMAB™ brand.

amsbiopr137Screening of candidate antibodies against greater than 10,000 human proteins, using a state-of-the-art High Density Protein Microarray Platform, has resulted in the identification of the most specific monoclonal antibodies (UltraMAB antibodies) available for cancer biomarkers and other important diagnostic targets.

Performance and specificity are key pre-requisites for antibodies to be used for diagnostic and therapeutic applications. To ensure the superior performance,every UltraMAB® monoclonal antibody is validated according to the scientific findings and the medical records of related diseases. Major applications of validation include Western Blot, Immunohistochemical staining with over 25 types of normal and cancer human tissues, Immunocytochemistry / Immunofluorescence, and Fluorescence-Activated Cell Sorting.

Some commonly used alternative diagnostic antibodies perform well in applications but cross-react with other unrelated proteins.This cross-reactivity may potentially cause unexpected side effects and generate false diagnostic reports for clinicians.

By contrast, each UltraMAB™ from AMSBIO is validated, and determined to have no cross reactivity with other human proteins other than the antibody’s intended target protein as determined by analysis on a 10K High Density Protein Microarray Platform. Consequently, each UltraMAB™ is quality control verified, guaranteeing superior performance for applications,where specificity-verification and the highest quality antibodies are critical for accurate detection.

AMSBIO antibodies are available in affordable small trial sample packs. All antibodies are guaranteed to work, or your money back. A free trial size HA-antibody is supplied with every primary UltraMAB antibody.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.


more about AMS biotechnology


more news from AMS biotechnology


 

 

 


If you have not logged into the website then please enter your details below.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events